Nexavar Approved for Treatment of Liver Cancer in China
- Details
- Category: Bayer

Nexavar Study Demonstrates Significant Improvement in Overall Survival
- Details
- Category: Bayer

Pfizer Reports Second-Quarter 2008 Results
- Details
- Category: Pfizer

GlaxoSmithKline teams up with academia to develop new medicines of value
- Details
- Category: GlaxoSmithKline

Novartis gains momentum with strong performance in first half of 2008
- Details
- Category: Novartis

- First-half results for continuing operations led by improving Pharmaceuticals performance ahead of expectations and expansion in Vaccines and Diagnostics
- Net sales rise 11% (+2% in local currencies) to USD 20.6 billion
- Operating income advances 12% to USD 4.9 billion on business expansion, productivity gains and currency benefits
Abbott Reports Stronger-than-Expected Sales and Earnings Growth in Second Quarter
- Details
- Category: Abbott

- Diluted earnings per share, excluding specified items, were $0.84, above Abbott's previously announced guidance range of $0.78 to $0.80, reflecting 21.7 percent growth. Diluted earnings per share under Generally Accepted Accounting Principles (GAAP) were $0.85, up 34.9 percent.
Boehringer Ingelheim FENS Award for exceptional research in neuroscience
- Details
- Category: Boehringer Ingelheim

More Pharma News ...
- Novartis completes acquisition of 25% stake in Alcon from Nestlé
- Patients More Likely to Stay on Lipitor Than Simvastatin, a Large Observational Study Shows
- Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
- Shire proposes acquisition of Jerini AG for an equity purchase price of €328 million
- Summary Judgment Granted for SEROQUEL Patent Litigation in the US
- GlaxoSmithKline responds to FDA on Cervarix® and plans to submit final study data for approval
- Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development